03/18/2024
6:10 AM | Syndax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2024
4:21 PM | Syndax Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/27/2024
4:28 PM | Syndax Pharmaceuticals (Filer)
| Form S-3ASR | |
02/27/2024
3:33 PM | Syndax Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2024
11:50 AM | Kynam Capital Management, LP (Filed by)
Syndax Pharmaceuticals (Subject)
| Form SC 13G | |
02/14/2024
6:01 AM | Point72 Asset Management, L.P. (Filed by)
Syndax Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/13/2024
8:44 PM | Avidity Partners Management LP (Filed by)
Syndax Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/08/2024
9:18 AM | Syndax Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
01/25/2024
10:20 AM | STATE STREET CORP (Filed by)
Syndax Pharmaceuticals (Subject)
| Form SC 13G/A | |
12/20/2023
7:40 AM | Syndax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/15/2023
4:29 PM | Syndax Pharmaceuticals (Filer)
| Form 424B5 | |
12/15/2023
4:29 PM | Syndax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/14/2023
3:30 PM | Syndax Pharmaceuticals (Filer)
| Form 424B5 | |
10/05/2023
11:23 AM | Frazier Life Sciences Public Fund, L.P. (Filed by)
Syndax Pharmaceuticals (Subject)
| Form SC 13G/A | |
10/02/2023
6:04 AM | Syndax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/10/2023
5:50 AM | Morrison Briggs (Reporting)
Syndax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/03/2023
8:12 AM | Meury William (Reporting)
Syndax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/02/2023
5:26 PM | Meury William (Reporting)
Syndax Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/24/2023
6:07 AM | Syndax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/11/2023
8:23 AM | Morrison Briggs (Reporting)
Syndax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2023
3:12 PM | Morrison Briggs (Reporting)
Syndax Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2023
3:20 PM | Goldan Keith A. (Reporting)
Syndax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
4:32 PM | Morrison Briggs (Reporting)
Syndax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/26/2023
3:39 PM | Syndax Pharmaceuticals (Filer)
| Form 424B5 | |
